F
Fabrice Barlesi
Researcher at Aix-Marseille University
Publications - 666
Citations - 36214
Fabrice Barlesi is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 64, co-authored 582 publications receiving 25403 citations. Previous affiliations of Fabrice Barlesi include Institut Gustave Roussy & Nord University.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of alectinib in ALK+ non-small-cell lung cancer (NSCLC): Pooled data from two pivotal phase II studies (NP28673 and NP28761).
James Chih-Hsin Yang,Sai-Hong Ignatius Ou,Luigi De Petris,Shirish M. Gadgeel,Leena Gandhi,Dong Wan Kim,Fabrice Barlesi,Ramaswamy Govindan,Anne-Marie C. Dingemans,Lucio Crinò,Hervé Lena,Sanjay Popat,Jin Seok Ahn,Eric Dansin,Sophie Golding,Walter Bordogna,Bogdana Balas,Peter N. Morcos,Ali Zeaiter,Alice T. Shaw +19 more
TL;DR: A pooled analysis further explored the efficacy and safety of alectinib in ALK+ NSCLC and assessed objective response rate (ORR; RECIST v1.1) by independent review committee and safety.
Journal ArticleDOI
Toxicités à prévoir avec les futures immunothérapies ou associations
TL;DR: De nombreuses nouvelles immunotherapies sont en cours de developpement, dont les mecanismes d’action sont varies, mais toujours dans le but de restaurer la reponse immunitaire anti-tumorale.
Journal ArticleDOI
Comment traiter la rechute du CBNPC après une chirurgie et chimiothérapie ? : Étude randomisée de phase III IFCT 0702
Denis Moro-Sibilot,Fabrice Barlesi,Jean-François Timsit,Didier Debieuvre,Pierre Fournel,Radj Gervais,Julien Mazieres,Bernard Milleron,Franck Morin,Maurice Pérol,J-C. Soria,Pierre-Jean Souquet,A. Vergnenegre,Gérard Zalcman +13 more
TL;DR: In this article, the authors propose an approach to determine the meilleure option therapeutique chez les patients en rechute apres une association of chirurgie and chimiotherapie.
Journal ArticleDOI
Second-line therapy with gefitinib in combination with docetaxel for advanced non-small cell lung cancer: a phase II randomized study
Gilles Robinet,Fabrice Barlesi,Pierre Fournel,Henri Berard,Romain Corre,A. Vergnenegre,Lionel Falchero,P-J. Souquet,A. Tisseron-Carrasco,Christos Chouaid +9 more
TL;DR: Gefitinib and docetaxel combination therapy has antitumor activity and may be a feasible treatment option in patients with advanced NSCLC who have failed platinum-based chemotherapy.
Journal ArticleDOI
Biobanques tumorales et gestion des données complexes : enjeux actuels et futurs
Paul Hofman,Georges Dagher,Pierre Laurent-Puig,Charles-Hugo Marquette,Fabrice Barlesi,Frédéric Bibeau,Bruno Clément +6 more
TL;DR: A review of the role of tumor banks in oncology is presented in this paper, where the authors briefly describe the current evolution of the biobanks, then their present and future challenges, and finally the role made by the pathologists in these new issues in the field.